Organisation
Hepatology
Division
The labo of Hepatology studies pathophysiology and treatment of liver and pancreas diseases and metabolism.
Current researchers
11 - 15 of 15 results
- Schalk Van der Merwe (Member)
- Emma Vanderschueren (Member)
- Jef Verbeek (Member)
- Hannah van Malenstein (Member)
- Matthias van Sligtenhorst (Member)
Projects
11 - 20 of 51
- Metabolic rewiring in SORDD polyneuropathy: unraveling a polyol pathway disorderFrom1 Oct 2021 → TodayFunding: FWO fellowships
- Liver transplantation for alcohol-related liver disease.From23 Jun 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Therapeutic endoscopic ultrasound: where are we and where do we go?From16 Mar 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Non-alcoholic fatty liver disease (NAFLD): Using single-cell RNA sequencing to profile adipose tissue macrophages.From1 Jan 2021 → 31 Dec 2022Funding: Private funding of national origin - undefined
- Breaching the intestinal barrier during cirrhosis: a cell-by-cell analysis of how diseased macrophages fail to prevent pathological bacterial translocation to the liverFrom1 Jan 2021 → 31 Dec 2022Funding: Private funding of national origin - undefined
- Cirrhosis on single cell level: transcriptional and metabolic profiles in the peritoneum unraveledFrom1 Jan 2021 → 31 Dec 2022Funding: Private funding of national origin - undefined
- Studying congenital disorders of glycosylation and their potential treatments using tracer metabolomicsFrom24 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Determining the role of hepatic and circulatory Immune Cells on a single cell level in the Onset and Treatment of severe Alcoholic Hepatitis: The DICOTAH study.From21 Sep 2020 → TodayFunding: FWO fellowships
- Translational research-oriented technology platform for single cell analysisFrom1 May 2020 → TodayFunding: BOF - scientific equipment program
- Acute-on-chronic liver failure (ACLF): monocyte profiles as a predictor for progression or recovery signatures in patients.From1 Dec 2019 → 31 May 2020Funding: Private funding of national origin - undefined
Publications
1 - 10 of 1340
- Polycystic Liver Disease(2010)
Authors: Frederik Nevens
Pages: 945 - 948 - Stratification based on acute on chronic liver failure (ACLF) has greater prognostic accuracy than stratification based on creatinine, Acute Kidney Injury (AKI), Encephalopathy or Child-Pugh Score. Prognostic relevance of 48 hour post-enrolment ACLF Stratification(2013)
Authors: Paolo Angeli, Pere Gines, Salvatore Piano, Elisabet Garcia, Filippo Morando, Ezequiel Rodriguez, Xavier Ariza, Elisabetta Gola, Elsa Sola, Monica Guevara, et al.
Pages: 273 - Pharmacokinetic interactions between simeprevir and ledispavir in treatment-naive hepatitis C virus genotype 1-infected without cirrhosis treated with a simeprevir/sofosbuvir/ledipasvir regimen(2016)
Authors: S Bourgeois, Y Horsmans, Frederik Nevens, H van Vlierberghe, C Moreno, M Beumont, J van de Logt, L Vijgen, V van Eygen, D Luo, et al.
Pages: S820 - S820 - KERATIN19: A KEY ROLE PLAYER IN THE INVASION OF HUMAN HEPATOCELLULAR CARCINOMAS WITH PROGENITOR CELL FEATURES(2012)
Authors: Olivier Govaere, MIna Komuta, B Spee, A Durnez, S Vander Borght, Chris Verslype, Raymond Aerts, Baki Topal, Jacques Pirenne, Frederik Nevens, et al.
Pages: S50 - S50 - The Patient Experience of Fatigue in Systemic Lupus Erythematosus: A Conceptual Model(2021)
Authors: Thomas Morel
Pages: 95 - 108 - OPTIMISING TRIAL DESIGN IN LATE-STAGE PRIMARY BILIARY CHOLANGITIS: EVALUATING OPTIONS FOR COMPOSITE CLINICAL ENDPOINT STUDIES(2019)
Authors: Carla Fiorella Murillo Perez, Willem J Lammers, Annarosa Floreani, Christophe Corpechot, Adriaan Van der Meer, Aliya Gulamhusein, Cyriel Ponsioen, Marco Carbone, Marlyn J Mayo, Pietro Invernizzi, et al.
Pages: 793A - 794A - RISK FACTORS FOR HEPATIC DECOMPENSATION IN PRIMARY BILIARY CIRRHOSIS - RESULTS OF AN INTERNATIONAL FOLLOW UP STUDY OF 2326 PATIENTS(2015)
Authors: MH Harms, WJ Lammers, P Invernizzi, PM Battezzati, A Floreani, A Pares, Frederik Nevens, D Thorburn, AL Mason, KV Kowdley, et al.
Pages: S795 - S795 - Liver transplantation in polycystic liver disease: excellent survival and improvement of quality of life(2009)
Authors: Loes van Keimpema, Frederik Nevens, Rene Adam, Robert J Porte, Panagiotis Fikatas, Thomas Becker, Preben Kirkegaard, Herold J Metselaar, Joost P Drenth
Pages: 562 - THE CLIF-CONSORTIUM SCORE PREDICTS MORTALITY MORE ACCURATELY THAN THE MELD AND MELD-SODIUM SCORES IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS WITH AND WITHOUT ACUTE-ON-CHRONIC-LIVER FAILURE (ACLF)(2013)
Authors: M Pavesi, R Jalan, A Amoros, R Moreau, P Gines, F Durand, P Angeli, P Caraceni, E Rodriguez, B Agarwarl, et al.
Pages: S568 - S569 - Treatment-naïve stable liver transplant patients with genotype-1 HCV infections: pharmacokinetic results of adjusted dosing with tacrolimus or cyclosporine in the telaprevir replace study(2014)
Authors: X Forns, D Samuel, D Mutimer, S Fagiouli, M Navasa, K Agarwal, M Berenguer, M Colombo, K Herzer, Frederik Nevens, et al.
Pages: S481 - S482